Viktoria Thurfjell
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Carina Strell
- E-post:
- viktoria.thurfjell@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Specialistläkare vid Institutionen för immunologi, genetik och patologi; Kliniska verksamheter; Klinisk patologi
- E-post:
- viktoria.thurfjell@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
75185 Uppsala - Postadress:
- Rudbecklaboratoriet
75185 Uppsala

Publikationer
Senaste publikationer
-
Ingår i Cell Communication and Signaling, 2026
- DOI för In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLC
- Ladda ner fulltext (pdf) av In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLC
-
Ingår i Breast Cancer Research, 2025
- DOI för Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study
- Ladda ner fulltext (pdf) av Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study
-
Ingår i Breast Cancer Research and Treatment, s. 499-509, 2025
- DOI för Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
- Ladda ner fulltext (pdf) av Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
-
Ingår i The Breast, 2025
- DOI för Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Ladda ner fulltext (pdf) av Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
-
Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Ingår i Archives of Pathology & Laboratory Medicine, 2024
- DOI för Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
- Ladda ner fulltext (pdf) av Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Alla publikationer
Artiklar i tidskrift
-
Ingår i Cell Communication and Signaling, 2026
- DOI för In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLC
- Ladda ner fulltext (pdf) av In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLC
-
Ingår i Breast Cancer Research, 2025
- DOI för Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study
- Ladda ner fulltext (pdf) av Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study
-
Ingår i Breast Cancer Research and Treatment, s. 499-509, 2025
- DOI för Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
- Ladda ner fulltext (pdf) av Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
-
Ingår i The Breast, 2025
- DOI för Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Ladda ner fulltext (pdf) av Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
-
Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Ingår i Archives of Pathology & Laboratory Medicine, 2024
- DOI för Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
- Ladda ner fulltext (pdf) av Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
-
Ingår i Translational Lung Cancer Research, s. 2477-2494, 2022
- DOI för Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
- Ladda ner fulltext (pdf) av Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
-
Ingår i European Journal of Cancer, s. 128-137, 2022
- DOI för Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
- Ladda ner fulltext (pdf) av Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
-
Ingår i Cancer Immunology and Immunotherapy, s. 2577-2587, 2021
- DOI för PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
- Ladda ner fulltext (pdf) av PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
-
Ingår i Clinical Cancer Research, s. 3469-3477, 2021